Centenary's Tuberculosis Research Group is the largest in Australasia.
TB is second only to HIV/AIDS as the greatest killer worldwide due to a single infectious agent.
In 2011, about 8.7 million people worldwide fell ill with tuberculosis and 1.4 million died.
Multi-drug resistant TB is present in almost all countries surveyed, and about nine per cent of multi-drug resistant cases are extensively drug resistant—sensitive to very few available medicines and treatments.
The latest NHMRC funding will help Centenary's ground-breaking research, such as in the T-Cell Biology lab, headed by Professor Barbara Fazekas de St Groth.
Centenary scientists have won over $5 million in the latest NHMRC grant round – with seven research grants and three early career fellowships.
The development of a TB vaccine, the genetic regulation of ageing, the fundamental workings of the immune system, the genetic basis of heart disease—these are some of the research areas of key interest to Centenary Institute for which the Australian Government has announced funding through the National Health and Medical Research Council (NHMRC).
Centenary also boasts three new NHMRC Early-Career Fellows along with seven significant research projects in the medical research funding released on Friday.
Dr Saparna Pai after being awarded her Early-Career Australia-India Fellowship.
A Centenary researcher is off to New Delhi to study the impact on cerebral malaria of the major ingredient of turmeric, curcumin.
Dr Saparna Pai has been awarded an Australian Academy of Science Early-Career Australia-India Fellowship to investigate curcumin’s action on immune cells during malaria infection. The Fellowships were announced by the Academy during the visit to India of the Prime Minister, Julia Gillard.
“It has long been known in India that curcumin is useful in treating malaria,” says Dr Pai, a post-doctoral fellow in Professor Wolfgang Weninger’s Immune Imaging laboratory at the Centenary Institute.
Mika Jormakka, the latest appointment to Faculty at Centenary.
We’re delighted to report the appointment of Associate Professor, Mika Jormakka, to Faculty at the Centenary Institute.
Mika is currently head of the Structural Biology group at Centenary, whose research into membrane transport in health and disease, aims to tailor drugs in order to increase their efficiency and to reduce side effects.